Eribulin Mesylate 00781-3391
Product NDC
00781-3391- Manufacturer
- Sandoz Inc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 7, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA214310
Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eribulin Mesylate | .5 mg/mL |
Drug Class
Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (0781-3391-94) / 2 mL in 1 VIAL